*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Factors Affecting Chronik Kidney Disease Costs : Systematic Review

Author: ENDANG SUNARIYANTI, TRI MURTI ANDAYANI, DWI ENDARTI, DIAH AYU PUSPANDARI
Abstract: Chronic Kidney Disease (CKD) is a disease with a high prevalence and mortality rate. The long treatment process and the high cost of treatment are things that need attention. Several studies reveal the factors of concomitant diseases, old age and the high cost of drugs consumed by patients to be one of the factors increasing the cost of treatment of Chronic Kidney Disease (CKD) in Hospitals. The purpose of this study is to carry out a systematic review of the factors that influence the cost of treatment in Chronic Kidney Disease (CKD). Researchers searched for articles within one month (January-February 2020). Searching articles through Pubmed and Google Scholar uses keywords: Cost of Illness, Cost Analysis, Chronic Kidney Failure, and Influence Factors. Researchers use PRISMA Diagrams (Preferred reporting items for systematic reviews) to help the selection of articles that fit the inclusion and exclusion criteria. Articles of original research type in English or Indonesian, full text and published within the last 10 years (2010-2020) are inclusion criteria. The results of our systematic review of 85 articles were obtained with 29 articles fulfilling the inclusion criteria while the rest were exclusion criteria. Our results reveal that comorbidities and the severity of Chronic Kidney Disease are factors that influence the cost of CKD treatment. The more comorbid patients have, the cost of treatment also increases. Neither is the severity of the disease. Our findings assess that patients with higher severity require greater treatment costs than patients with mild severity. Hemodialysis (HD) and peritonial dialysis (HD) also contribute to the patient's significant costs.
Keyword: Cost of Illness, Cost Analysis, Chronic Kidney Disease, Factor Affecting
DOI: https://doi.org/10.31838/ijpr/2021.13.01.644
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free